IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STEPHEN J SCHUSTER

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1033147566
CMS profile
138084
Location
PHILADELPHIA, PA

General Payments · PY2018–2024

$231,315.10

  • Reported across 221 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$48,935.79

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Hematology & Oncology PA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $25,301.50 6
Travel and Lodging $21,327.62 8
Food and Beverage $2,306.67 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $20,838.37 12
Acerta Pharma LLC $12,653.57 8
Janssen Scientific Affairs, LLC $4,050.00 1
E.R. Squibb & Sons, L.L.C. $3,342.50 1
Genmab U.S., Inc. $2,554.41 5
BeiGene USA, Inc. $2,386.41 3
ADC Therapeutics America, Inc. $1,379.94 9
BioNTech SE $1,088.00 1
NOVARTIS PHARMACEUTICALS CORPORATION $312.80 5
Genentech USA, Inc. $174.06 2
Celgene Corporation $113.14 3
Janssen Global Services, LLC $42.59 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $36,314.65 51
PY2019 $46,347.95 52
PY2020 $49,981.51 18
PY2021 $11,847.00 7
PY2022 $19,916.90 15
PY2023 $17,971.30 27
PY2024 $48,935.79 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $84.69 02/01/2024 Food and Beverage Undisputed 01/23/2026 1106043894 CMS
ABBVIE INC. $301.03 06/11/2024 Travel and Lodging Undisputed 01/23/2026 1106043896 CMS
ABBVIE INC. $213.67 06/11/2024 Travel and Lodging Undisputed 01/23/2026 1106043898 CMS
ABBVIE INC. $60.19 06/12/2024 Food and Beverage Undisputed 01/23/2026 1106043900 CMS
ABBVIE INC. $301.03 06/12/2024 Travel and Lodging Undisputed 01/23/2026 1106043902 CMS
ABBVIE INC. $18,410.50 06/13/2024 Travel and Lodging Undisputed 01/23/2026 1106043904 CMS
ABBVIE INC. $288.22 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1106043906 CMS
ABBVIE INC. $150.00 11/15/2024 Food and Beverage Undisputed 01/23/2026 1106043908 CMS
ABBVIE INC. $841.78 11/16/2024 Travel and Lodging Undisputed 01/23/2026 1106043910 CMS
ABBVIE INC. $50.00 11/16/2024 Food and Beverage Undisputed 01/23/2026 1106043912 CMS
ABBVIE INC. $10.00 11/16/2024 Food and Beverage Undisputed 01/23/2026 1106043914 CMS
ABBVIE INC. $127.26 12/06/2024 Food and Beverage Undisputed 01/23/2026 1106043916 CMS
ADC Therapeutics America, Inc. $22.60 08/09/2024 Food and Beverage Undisputed 01/23/2026 1121185590 CMS
ADC Therapeutics America, Inc. $83.87 08/10/2024 Food and Beverage Undisputed 01/23/2026 1121185592 CMS
ADC Therapeutics America, Inc. $694.75 09/09/2024 Travel and Lodging Undisputed 01/23/2026 1121185688 CMS
ADC Therapeutics America, Inc. $143.89 10/04/2024 Food and Beverage Undisputed 01/23/2026 1121185678 CMS
ADC Therapeutics America, Inc. $49.00 10/04/2024 Food and Beverage Undisputed 01/23/2026 1121185680 CMS
ADC Therapeutics America, Inc. $64.00 10/04/2024 Food and Beverage Undisputed 01/23/2026 1121185682 CMS
ADC Therapeutics America, Inc. $39.00 10/04/2024 Food and Beverage Undisputed 01/23/2026 1121185684 CMS
ADC Therapeutics America, Inc. $276.64 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1121185686 CMS
ADC Therapeutics America, Inc. $6.19 12/09/2024 Food and Beverage Undisputed 01/23/2026 1121185622 CMS
AstraZeneca Pharmaceuticals LP $10.76 02/08/2024 Food and Beverage Undisputed 01/23/2026 1110553166 CMS
AstraZeneca Pharmaceuticals LP $106.76 02/12/2024 Food and Beverage Undisputed 01/23/2026 1110546433 CMS
AstraZeneca Pharmaceuticals LP $124.58 02/12/2024 Food and Beverage Undisputed 01/23/2026 1110548930 CMS
AstraZeneca Pharmaceuticals LP $15.33 02/12/2024 Food and Beverage Undisputed 01/23/2026 1110552010 CMS
AstraZeneca Pharmaceuticals LP $25.12 02/13/2024 Food and Beverage Undisputed 01/23/2026 1110538757 CMS
AstraZeneca Pharmaceuticals LP $25.12 02/13/2024 Food and Beverage Undisputed 01/23/2026 1110543071 CMS
AstraZeneca Pharmaceuticals LP $15.90 02/13/2024 Food and Beverage Undisputed 01/23/2026 1110548284 CMS
AstraZeneca Pharmaceuticals LP $12,330.00 05/28/2024 Consulting Fee Undisputed 01/23/2026 1110546571 CMS
BeiGene USA, Inc. $104.38 08/09/2024 Food and Beverage Undisputed 01/23/2026 1120849442 CMS
BeiGene USA, Inc. $2,250.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1120861937 CMS
BeiGene USA, Inc. $32.03 12/07/2024 Food and Beverage Undisputed 01/23/2026 1120861939 CMS
BioNTech SE $1,088.00 01/02/2024 Consulting Fee Undisputed 01/23/2026 1150660488 CMS
Celgene Corporation $26.94 12/10/2024 Food and Beverage Undisputed 01/23/2026 1101116824 CMS
Celgene Corporation $26.94 12/10/2024 Food and Beverage Undisputed 01/23/2026 1101116826 CMS
Celgene Corporation $59.26 12/10/2024 Food and Beverage Undisputed 01/23/2026 1101116828 CMS
E.R. Squibb & Sons, L.L.C. $3,342.50 12/20/2024 Consulting Fee Undisputed 01/23/2026 1101353810 CMS
Genentech USA, Inc. $120.56 05/10/2024 Food and Beverage Undisputed 01/23/2026 1133116733 CMS
Genentech USA, Inc. $53.50 12/06/2024 Food and Beverage Undisputed 01/23/2026 1133116737 CMS
Genmab U.S., Inc. $2,241.00 01/11/2024 Consulting Fee Undisputed 01/23/2026 1126832321 CMS
Genmab U.S., Inc. $61.43 03/11/2024 Food and Beverage Undisputed 01/23/2026 1126832313 CMS
Genmab U.S., Inc. $149.83 08/01/2024 Food and Beverage Undisputed 01/23/2026 1126832315 CMS
Genmab U.S., Inc. $83.00 08/14/2024 Food and Beverage Undisputed 01/23/2026 1126832317 CMS
Genmab U.S., Inc. $19.15 10/02/2024 Food and Beverage Undisputed 01/23/2026 1126832319 CMS
Janssen Global Services, LLC $42.59 12/05/2024 Food and Beverage Undisputed 01/23/2026 1077592235 CMS
Janssen Scientific Affairs, LLC $4,050.00 05/09/2024 Consulting Fee Undisputed 01/23/2026 1078862417 CMS
Novartis Pharmaceuticals Corporation $50.60 02/15/2024 Food and Beverage Undisputed 01/23/2026 1087156359 CMS
Novartis Pharmaceuticals Corporation $135.00 07/24/2024 Food and Beverage Undisputed 01/23/2026 1087156367 CMS
Novartis Pharmaceuticals Corporation $55.60 08/22/2024 Food and Beverage Undisputed 01/23/2026 1087156365 CMS
Novartis Pharmaceuticals Corporation $35.50 10/10/2024 Food and Beverage Undisputed 01/23/2026 1087156377 CMS
Novartis Pharmaceuticals Corporation $36.10 12/07/2024 Food and Beverage Undisputed 01/23/2026 1087156379 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.